ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study.

Name: ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study.
Author: Hauser, Robert A

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study. — المؤلف: Hauser, Robert A — Journal of Parkinson's disease 20180430

المؤلف: Hauser, Robert A
النشر: Journal of Parkinson's disease 20180430
الوصف: 511-522 p.
الموضوعات: Aged؛ Amantadine؛ Double-Blind Method؛ Drug Delivery Systems؛ Dyskinesia, Drug-Induced؛ Female؛ Humans؛ Kaplan-Meier Estimate